|
|
|
About Initiative
Accreditation Faculty Workshops Point of Care Webcast on Demand  Live webcast Outcomes Jointly sponsored by University of Kentucky College of Pharmacy and Vemco MedEd  This activity is supported by an educational grant from Janssen Pharmaceuticals, Inc., administered by Janssen Scientific Affairs, LLC 
|
The online tutorial series with a case reinforces practical
application of tools and competencies acquired during the
live activity. Each tool is a combination of essentials in
clinical practice, links to relevant scientific publications, and
printable handout material for reference. Clinical Case
following the online tutorials gives the learners an opportunity
to earn extra CE credit upon completion.
Would you alter or discontinue pregabalin treatment for this patient? Pregabalin is indicated for the treatment of fibromyalgia and has demonstrated efficacy in randomized clinical trials.3,4 However, the dose used to treat fibromyalgia is typically much higher than what is currently prescribed for Emily. Though the recommended starting dose for pregabalin is 150 mg/day, the dose can be titrated to 300-450 mg/day for the treatment of fibromyalgia. Since Emily complains of "pain all over," the clinician should consider increasing the dose of pregabalin. What other changes would you consider for this patient? |
Home About Us What We Do CME Portal Register for Programs Outcomes Reports Contact Us | Legal | Privacy Statement |